The MIF receptor CD74 in diabetic podocyte injury

Journal of the American Society of Nephrology

Volumn 20, Issue 2, 2009, Pages 353-362

  Sanchez Niño, Maria Dolores ^a   Sanz, Ana Belen ^a   Ihalmo, Pekka ^b   Lassila, Markus ^c   Holthofer, Harry ^d   Mezzano, Sergio ^e   Aros, Claudio ^e   Groop, Per Henrik ^b   Saleem, Moin A ^f   Mathieson, Peter W ^f   Langham, Robert ^g   Kretzler, Matthias ^h   Nair, Viji ^h   Lemley, Kevin V ⁱ   Nelson, Robert G ^j   Mervaala, Eero ^b   Mattinzoli, Deborah ^k   Rastaldi, Maria Pia ^k   Ruiz Ortega, Marta ^a   Martin Ventura, Jose Luis ^a   Ortiz, Jesus Egidoalberto ^a,l   more..

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d DUBLIN CITY UNIVERSITY   (Ireland)

^e UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ CHILDREN S HOSPITAL LOS ANGELES   (United States)

^j NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^k Fondazione d'Amico per la Ricerca Sulle Malattie Renali   (Italy)

^l Hospital UniversitarioFundación Jiménez Díaz   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN CD74; RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INDIAN; KIDNEY PROXIMAL TUBULE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION;

EID: 59949089766     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008020194     Document Type: Article

References (33)

1. Mora C, Navarro JF: Inflammation and diabetic nephropathy. Curr Diab Rep 6: 463-468, 2006
2. Tesch GH: MCP-1/CCL2: A new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294: F697-F701, 2008
3. Lorz C, Benito-Martin A, Boucherot A, Ucero AC, Rastaldi MP, Henger A, Armelloni S, Santamaria B, Berthier CC, Kretzler M, Egido J, Ortiz A: The death ligand TRAIL in diabetic nephropathy. J Am Soc Nephrol 19: 904-914, 2008
4. Morand EF, Leech M, Bernhagen J: MIF: A new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5: 399 -410, 2006
5. Lan HY, Yang N, Nikolic-Paterson DJ, Yu XQ, Mu W, Isbel NM, Metz CN, Bucala R, Atkins RC: Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57: 499-509, 2000
6. Rice EK, Nikolic-Paterson DJ, Hill PA, Metz CN, Bucala R, Atkins RC, Tesch GH: Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells. Nephrology (Carlton) 8: 156-161, 2003
7. Rice EK, Tesch GH, Cao Z, Cooper ME, Metz CN, Bucala R, Atkins RC, Nikolic-Paterson DJ: Induction of MIF synthesis and secretion by tubular epithelial cells: A novel action of angiotensin II. Kidney Int 63: 1265-1275, 2003
8. Sasaki S, Nishihira J, Ishibashi T, Yamasaki Y, Obikane K, Echigoya M, Sado Y, Ninomiya Y, Kobayashi K: Transgene ofMIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney. Kidney Int 65: 469-481, 2004
9. Brown FG, Nikolic-Paterson DJ, Hill PA, Isbel NM, Dowling J, Metz CM, Atkins RC: Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol 13[Suppl 1]: S7-S13, 2002
10. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH: Maro-phages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury. Kidney Int 65: 116 -128, 2004
11. Herder C, Kolb H, Koenig W, Haastert B, Muller-Scholze S, Rathmann W, Holle R, Thorand B, Wichmann HE: Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: Results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care 29: 368-371, 2006
12. Tashimo A, Mitamura Y, Nagai S, Nakamura Y, Ohtsuka K, Mizue Y, Nishihira J: Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy. Diabet Med 21: 1292-1297, 2004
13. David JR: Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Aca Sci U S A 56: 72-77, 1966
14. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, DeloheryT, Chen Y, Mitchell RA, Bucala R: MIF signal transduction initiated by binding to CD74. J Exp Med 197: 1467-1476, 2003
15. Becker-Herman S, Arie G, Medvedovsky H, Kerem A, Shachar I: CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol Biol Cell 16: 5061-5069, 2005
16. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, Eichinger F, Nitsche A, Kiss E, Bleich M, Grone HJ, Nelson PJ, Schlondorff D, Cohen CD, Kretzler M: Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003, 2006
17. Houghton AN, Thomson TM, Gross D, Oettgen HF, Old LJ: Surface antigens of melanoma and melanocytes: Specificity of induction of Ia antigens by human gamma-interferon. J Exp Med 160: 255-269, 1984
18. Leng L, Bucala R: Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor. Cell Res 16: 162-168, 2006
19. Navarro JF, Mora-Fernandez C: The role of TNF-alpha in diabetic nephropathy: Pathogenic and therapeutic implications. Cytokine Growth Factor Rev 17: 441-450, 2006
20. Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K: Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 16: 2690-2701, 2005
21. Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Hara A, Yamahana J, Okumura T, Takasawa K, Takeda S, Yoshimura M, Kida H, Yokoyama H: Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis 45: 54-65, 2005
22. Roux PP, Blenis J: ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68: 320-344, 2004
23. Adams JL, Badger AM, Kumar S, Lee JC: p38 MAP kinase: Molecular target for the inhibition of pro-inflammatory cytokines. Prog Med Chem 38: 1-60, 2001
24. Kimura C, Zhao QL, Kondo T, Amatsu M, Fujiwara Y: Mechanism of UV-induced apoptosis in human leukemia cells: roles of Ca2+/ Mg(2+)-dependent endonuclease, caspase-3, and stress-activated protein kinases. Exp Cell Res 239: 411-422, 1998
25. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J: Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 110: 357-368, 1997
26. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108: 807-816, 2001
27. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13: 630-638, 2002
28. Coward RJ, Welsh GI, Koziell A, Hussain S, Lennon R, Ni L, Tavare JM, Mathieson PW, Saleem MA: Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 56: 1127-1135, 2007
29. Justo P, Sanz A, Lorz C, Gomez-Garre D, Mezzano S, Egido J, Ortiz A: Expression of Smac/Diablo in tubular epithelial cells and during acute renal failure. Kidney Int Suppl S52-S56, 2003
30. Ortiz A, Ziyadeh FN, Neilson EG: Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 45: 50-56, 1997
31. Sanz AB, Justo P, Sanchez-Nino MD, Blanco-Colio LM, Winkles JA, Kreztler M, Jakubowski A, Blanco J, Egido J, Ruiz-Ortega M, Ortiz A: The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol 19: 695-703, 2008
32. Lorz C, Ortiz A, Justo P, Gonzalez-Cuadrado S, Duque N, Gomez-Guerrero C, Egido J: Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 11: 1266-1277, 2000
33. Ihalmo P, Rinta-Valkama J, Mai P, Astrom E, Palmen T, Pham TT, Floss T, Holthofer H: Molecular cloning and characterization of an endogenous antisense transcript of Nphs1. Genomics 83: 1134-1140, 2004